We target cancer at its biological roots. Sat Prabhava uses metabolic and genomic insights to block cancer’s growth pathways offering precision therapies and nutritional strategies that starve tumours while empowering healthy recovery.
Disrupting Cancer’s Fuel and Growth Pathways with Precision
Our targeted and metabolic cancer therapies focus on disrupting the biological pathways and fuel sources cancer depends on. Using genomic and transcriptomic testing, we identify actionable mutations and metabolic dependencies to guide targeted therapies and metabolic interventions.
We offer small-molecule inhibitors, anti-angiogenic agents, and metabolic modulators that block cancer’s growth and spread. Additionally, we implement metabolic diet strategies such as low-glucose or ketogenic protocols, fasting-mimicking therapies, and supportive nutraceuticals to enhance tumour control and reduce treatment resistance.
Sat Prabhava’s approach is ideal for drug-resistant cancers, molecularly defined tumours, and patients seeking alternatives to standard protocols. All metabolic treatments are monitored with biomarker tracking, imaging, and quality-of-life assessments to ensure safety and sustained benefit.
“We don’t just treat cancer—we interrupt its survival systems. Our targeted and metabolic therapies strike cancer where it’s vulnerable, helping you regain control with clarity and care.”